Raymond K. Cross

6.9k total citations
204 papers, 4.0k citations indexed

About

Raymond K. Cross is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Raymond K. Cross has authored 204 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 154 papers in Genetics, 115 papers in Epidemiology and 69 papers in Surgery. Recurrent topics in Raymond K. Cross's work include Inflammatory Bowel Disease (154 papers), Microscopic Colitis (90 papers) and Eosinophilic Esophagitis (36 papers). Raymond K. Cross is often cited by papers focused on Inflammatory Bowel Disease (154 papers), Microscopic Colitis (90 papers) and Eosinophilic Esophagitis (36 papers). Raymond K. Cross collaborates with scholars based in United States, Italy and Canada. Raymond K. Cross's co-authors include Keith T. Wilson, Joseph Finkelstein, Leon McLean, Mark Flasar, Sandra Quezada, Patricia Langenberg, Seema Patil, David G. Binion, Anita Afzali and Francis A. Farraye and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Gastroenterology.

In The Last Decade

Raymond K. Cross

191 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raymond K. Cross United States 34 2.4k 1.6k 997 564 432 204 4.0k
Christopher F. Martin United States 36 1.8k 0.8× 1.4k 0.9× 1.5k 1.5× 585 1.0× 259 0.6× 105 4.5k
C Probert United Kingdom 39 2.2k 0.9× 1.8k 1.1× 1.2k 1.2× 726 1.3× 139 0.3× 172 4.6k
Joseph D. Feuerstein United States 30 2.1k 0.9× 1.5k 0.9× 1.1k 1.1× 577 1.0× 123 0.3× 171 4.4k
Nilesh Chande Canada 30 1.8k 0.8× 1.6k 1.0× 872 0.9× 308 0.5× 100 0.2× 95 3.2k
Lee A. Denson United States 47 2.4k 1.0× 1.7k 1.0× 1.8k 1.8× 1.4k 2.4× 347 0.8× 235 7.2k
Natalie A. Molodecky United States 17 3.0k 1.3× 2.2k 1.4× 1.7k 1.7× 780 1.4× 94 0.2× 25 5.2k
Pilar Nos Spain 29 1.6k 0.7× 1.3k 0.8× 849 0.9× 423 0.8× 86 0.2× 175 3.0k
Greg Chernoff United States 5 2.5k 1.1× 1.7k 1.0× 1.4k 1.4× 679 1.2× 78 0.2× 9 4.1k
Mollie Ferris Canada 4 2.5k 1.1× 1.7k 1.1× 1.4k 1.4× 678 1.2× 78 0.2× 7 4.1k
Jana G. Hashash United States 31 1.6k 0.7× 1.4k 0.9× 1.1k 1.1× 423 0.8× 86 0.2× 249 3.7k

Countries citing papers authored by Raymond K. Cross

Since Specialization
Citations

This map shows the geographic impact of Raymond K. Cross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond K. Cross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond K. Cross more than expected).

Fields of papers citing papers by Raymond K. Cross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond K. Cross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond K. Cross. The network helps show where Raymond K. Cross may publish in the future.

Co-authorship network of co-authors of Raymond K. Cross

This figure shows the co-authorship network connecting the top 25 collaborators of Raymond K. Cross. A scholar is included among the top collaborators of Raymond K. Cross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymond K. Cross. Raymond K. Cross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hanauer, Stephen B., et al.. (2025). The position of anti-tumor necrosis factor agents for the treatment of adult patients with Crohn’s disease. Expert Review of Gastroenterology & Hepatology. 19(7). 725–743. 2 indexed citations
2.
Barnes, Edward L., Laura E. Raffals, Taha Qazi, et al.. (2025). A Prospective Comparison of Ustekinumab and Antitumor Necrosis Factor α Therapy in the Treatment of Crohn's-Like Disease of the Pouch. The American Journal of Gastroenterology.
3.
Fiorino, Gionata, Ashwin N. Ananthakrishnan, Raymond K. Cross, et al.. (2025). Accelerating Earlier Access to Anti-TNF-α Agents with Biosimilar Medicines in the Management of Inflammatory Bowel Disease. Journal of Clinical Medicine. 14(5). 1561–1561. 1 indexed citations
4.
Alizadeh, Madeline, Bernadette C. Siaton, Michael France, et al.. (2025). The intestinal mucosa-associated microbiota in IBD-associated arthritis displays lower relative abundance of Roseburia intestinalis. Gut Microbes. 17(1). 2505114–2505114. 1 indexed citations
5.
Raine, Tim, Silvio Danese, Stefan Schreiber, et al.. (2024). DOP64 Steroid-sparing effect of risankizumab vs ustekinumab in patients with moderately to severely active Crohn’s Disease: Post hoc results from the phase 3b SEQUENCE trial. Journal of Crohn s and Colitis. 18(Supplement_1). i189–i189. 2 indexed citations
6.
7.
Kayal, Maia, Parakkal Deepak, Poonam Beniwal‐Patel, et al.. (2023). Changes in Therapy Are Not Associated With Increased Remission in Patients With Crohn's Disease of the Pouch. The American Journal of Gastroenterology. 119(3). 584–587. 4 indexed citations
8.
Barnes, Edward L., Poonam Beniwal‐Patel, Parakkal Deepak, et al.. (2023). Dietary Patterns Are Not Associated With Disease Activity Among Patients With Inflammatory Conditions of the Pouch in a Prospective Cohort. Crohn s & Colitis 360. 5(3). otad039–otad039. 1 indexed citations
9.
Alizadeh, Madeline, et al.. (2023). PREDICTORS OF DEVELOPING MULTIPLE EXTRA-INTESTINAL MANIFESTATIONS OF INFLAMMATORY BOWEL DISEASE. Gastroenterology. 164(4). S36–S37. 1 indexed citations
10.
Wu, Angela Ruohao, et al.. (2023). Current Screening and Management Strategies for Dysplasia in IBD. Current Treatment Options in Gastroenterology. 21(2). 218–230. 1 indexed citations
11.
Dulai, Parambir S., Victoria Rai, Laura E. Raffals, et al.. (2022). Recommendations on the Appropriate Management of Steroids and Discharge Planning During and After Hospital Admission for Moderate-Severe Ulcerative Colitis: Results of a RAND Appropriateness Panel. The American Journal of Gastroenterology. 117(8). 1288–1295. 5 indexed citations
12.
Axelrad, Jordan E., Millie D. Long, Sara Horst, et al.. (2022). A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With Inflammatory Bowel Disease Therapy (ASSIST Study): Protocol for a Randomized Controlled Trial. JMIR Research Protocols. 11(12). e40382–e40382. 4 indexed citations
13.
Barnes, Edward L., Parakkal Deepak, Poonam Beniwal‐Patel, et al.. (2022). Treatment Patterns and Standardized Outcome Assessments Among Patients With Inflammatory Conditions of the Pouch in a Prospective Multicenter Registry. Crohn s & Colitis 360. 4(3). otac030–otac030. 9 indexed citations
14.
15.
Lewis, James D., Raymond K. Cross, Millie D. Long, et al.. (2022). High Degree of Practice Variability in Colonic Dysplasia Surveillance for Patients With Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 28(8). 1289–1292. 2 indexed citations
16.
Weaver, Kimberly N., Xian Zhang, Xiangfeng Dai, et al.. (2021). Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID. Inflammatory Bowel Diseases. 28(10). 1497–1505. 63 indexed citations
17.
Farraye, Francis A., et al.. (2018). A State-of-the-Art Review of New and Emerging Therapies for the Treatment of IBD. Inflammatory Bowel Diseases. 25(5). 820–830. 89 indexed citations
18.
Afzali, Anita & Raymond K. Cross. (2016). Racial and Ethnic Minorities with Inflammatory Bowel Disease in the United States. Inflammatory Bowel Diseases. 22(8). 2023–2040. 78 indexed citations
19.
Gulati, Abhishek, Kofi Clarke, Julia B. Greer, et al.. (2016). IBD LIVE Case Series–Case 4. Inflammatory Bowel Diseases. 22(6). 1462–1472. 1 indexed citations
20.
Gobert, Alain P., Yulan Cheng, Mahmood Akhtar, et al.. (2004). Protective Role of Arginase in a Mouse Model of Colitis. The Journal of Immunology. 173(3). 2109–2117. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher F. Martin Breakdown of academic impact, for papers by C Probert Breakdown of academic impact, for papers by Joseph D. Feuerstein Breakdown of academic impact, for papers by Nilesh Chande Breakdown of academic impact, for papers by Lee A. Denson Breakdown of academic impact, for papers by Natalie A. Molodecky Breakdown of academic impact, for papers by Pilar Nos Breakdown of academic impact, for papers by Greg Chernoff Breakdown of academic impact, for papers by Mollie Ferris Breakdown of academic impact, for papers by Jana G. Hashash
Rankless by CCL
2026